Date: August 31st, 2011
YOLO Medical Inc. is proud to announce it will be presenting 4 of its clinical abstracts at the upcoming International Federation for Adipose Therapeutics and Science (IFATS)
YOLO Medical Inc. is the only company to have 4 individual papers accepted for presentation at the 9th annual conference November 4 - 6, 2011 in Miami Beach, Florida.
IFATS objective is to bring together as members, professionals of the science, medical and industry areas for productive collaborations around the adipose tissue research in all its possible fields. IFATS is currently the world's only interdisciplinary fat tissue society. They are committed to serve as the premier global incubator in the field of fat applied technology.
The abstract titled - Non-invasive Body Contouring and Spot Fat Reduction by Low Level Laser Therapy: Efficacy of LipoLaser Technology from a Single Center, Controlled Clinical Study - will be the first paper demonstrating the effectiveness of YOLO Medical Inc.'s 4th generation laser, the YOLO Curve.
Over the next coming months more of this exciting research will be revealed in the YOLO Change newsletter so please stay tuned.
Noninvasive Body Contouring and Spot Fat Reduction by Low Level Laser Therapy: Efficacy of Lipolaser Technology from a Single Center, Controlled Clinical Study
Vinod Podichetty, MD,MS; Jonas C. LaForge, BSc.,ND;
1-Research Practice Partners Inc. Miami, FL USA; 2-YOLO Medical Inc., Whiterock, BC
Advances in laser technology, particularly the use of low level laser therapy (LLLT) for body contouring and spot fat reduction has the potential to greatly decrease the need for invasive procedures. We report results from a cohort of patients assessing the efficacy of semiconductor based low level laser device for noninvasive body contouring and abdominal fat reduction.
Eligible healthy adult subjects were enrolled into a study and all patients received nine 30 minute laser treatments utilizing low level laser device at 658nm wavelength (YOLO Curve, YOLO Medical Inc.), 3 times per week for 3 weeks totaling nine treatment sessions and evaluated over a 9-week period. Efficacy outcomes included reduction of waist circumference, patient satisfaction and photographic assessment by blinded independent observers. Safety was monitoring by study physician.
Nineteen healthy men and women between the ages of 23-58 years (average age=39.9 years) formed the study sample (n=19). 4 men and 15 women received a complete nine treatment session protocol which was well tolerated producing a mean waist circumference reduction of 5.7inches with majority of the inch loss effect achieved within the first week. Responses after three treatment sessions in both genders were comparable, with a mean circumference reduction of 0.9 inches in men and 1.0 inches in women. (p=0.302). Overall at the end of the 9th treatment session, the average circumference reduction above the umbilicus=1.76 inches, at umbilicus =2.05 inches and below the umbilicus =1.98 (average cumulative loss =5.76 inches or 14.6 cms) Results varied between a range of 1 3/8 inch to 9 inches lost over the series of treatments. The effects were sustained at mean follow-up of 3 months post therapy. Independent observers found 75-100% improvement in abdominal contour in 90% of subjects and 50-74% improvement in 10% of subjects. No adverse event was reported.
Low level laser therapy is an effective non-invasive method for reducing subcutaneous fat of the abdomen and photographic evaluation correlates well with clinical findings.
View all this month's YOLO articles and announcements by Downloading this month's Newsletter.